Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials

Journal of Affective Disorders

Volumn 152-154, Issue 1, 2014, Pages 97-104

  Friedman, E S ^a   Calabrese, J R ^b   Ketter, T A ^c   Leon, A C ^d   Thase, M E ^e   Bowden, C L ^f   Sylvia, L G ^g   Ostracher, M J ^c   Severe, J ^h   Iosifescu, D V ⁱ   Nierenberg, A A ^g   Reilly Harrington, N A ^g  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Baseline characteristics; Bipolar; Comparative effectiveness; Generalizability

Indexed keywords

LITHIUM; MOOD STABILIZER; PLACEBO; LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; EMOTIONAL DISORDER; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEALTH STATUS; HOSPITALIZATION; HUMAN; HYPOMANIA; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; OBESITY; ONSET AGE; POVERTY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SINGLE BLIND PROCEDURE; STRUCTURED INTERVIEW; STUDY DESIGN; SUICIDE ATTEMPT; YOUNG MANIA RATING SCALE; ADOLESCENT; AGED; BIPOLAR DISORDER; CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; PROCEDURES; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; COMPARATIVE EFFECTIVENESS RESEARCH; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RESEARCH DESIGN; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84889084145     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.05.052     Document Type: Article

References (37)

1. R.J. Baldessarini, L. Leahy, S. Arcona, D. Gause, W. Zhang, and J. Hennen Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders Psychiatric Services 58 2007 85 91
2. M.S. Bauer, G.F. Kirk, C. Gavin, and W.O. Williford Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study Journal of Affective Disorders 65 2001 231 241
3. C.L. Bowden, E. Vieta, K.S. Ice, J.H. Schwartz, P.P. Wang, and M. Versavel Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial Journal of Clinical Psychiatry 71 2010 130 137
4. C.L. Bowden, J.R. Calabrese, S.L. McElroy, L. Gyulai, A. Wassef, F. Petty, H.G. Pope, J.C.Y. Chou, P.E. Keck Jr.; L.L. Rhodes, A.C. Swann, R.M.A. Hirschfeld, P.J. Wozniak Divalproex Maintenance Study Group A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder Archives of General Psychiatry 57 2000 481 489
5. C.L. Bowden, J.R. Calabrese, G. Sachs, L.N. Yatham, S.A. Asghar, M. Hompland, P. Montgomery, N. Earl, T.M. Smoot, J. DeVeaugh-Geiss Lamictal 605 Study Group A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Archives of General Psychiatry 60 2003 392 400
6. J.R. Calabrese, C.L. Bowden, G.S. Sachs, J.A. Ascher, E. Monaghan, G.D. Rudd Lamictal 605 Study Group A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression Journal of Clinical Psychiatry 60 1999 79 88
7. J.R. Calabrese, T. Suppes, C.L. Bowden, G.S. Sachs, A.C. Swann, S.L. McElroy, V. Kusumakar, J.A. Ascher, N.L. Earl, P.L. Greene, E.T. Monaghan Lamictal 605 Study Group A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder Journal of Clinical Psychiatry 61 2000 841 850
8. J.R. Calabrese, C.L. Bowden, G. Sachs, L.N. Yatham, K. Behnke, O.P. Mehtonen, P. Montgomery, J. Ascher, W. Paska, N. Earl, J. DeVeaugh-Geiss Lamictal 605 Study Group A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder Journal of Clinical Psychiatry 64 2003 1013 1024
9. J.R. Calabrese, P.E. Keck, Fadden W. Mac, M. Minkwitz, T.A. Ketter, R.H. Weisler, A.J. Cutler, R. Mccoy, E. Wilson, and J. Mullen A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression American Journal of Psychiatry 162 2005 1351 1360
10. J.R. Calabrese, and D.E. Kemp Bipolar drug development: are we getting closer to the real world? American Journal of Psychiatry 165 2008 1234 1235
11. W. Coryell, W. Scheftner, M. Keller, J. Endicott, J. Maser, and G.L. Klerman The enduring psychosocial consequences of mania and depression American Journal of Psychiatry 150 1993 720 727
12. A. Fagiolini, D.J. Kupfer, J. Scott, H.A. Swartz, D. Cook, D.M. Novick, and E. Frank Hypothyroidism in patients with bipolar I disorder treated primarily with lithium Epidemiologia e Psichiatria Sociale 15 2006 123 127
13. R.Z. Goetzel, K. Hawkins, R.J. Ozminkowski, and S. Wang The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999 Journal of Occupational and Environmental Medicine 45 2003 5 14
14. J.F. Goldberg, M. Harrow, and L.S. Grossman Course and outcome in bipolar affective disorder: a longitudinal follow up study American Journal of Psychiatry 152 3 1995 379 384
15. F.K. Goodwin, and K.R. Jamison Manic-Depressive Illness 2007 Oxford University Press New York
16. E.C. Harris, and B. Barraclough Suicide as an outcome for mental disorders: a meta-analysis British Journal of Psychiatry 170 1997 205 228
17. P.E. Keck, S.L. McElroy, S.M. Strakowski, S.A. West, K.W. Sax, J.M. Hawkins, M.L. Bourne, and P. Haggard 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode American Journal of Psychiatry 155 1998 646 652
18. P.E. Keck Jr.; R. Marcus, S. Tourkodimitris, M. Ali, A. Liebeskind, A. Saha, G. Ingenito Aripiprazole Study Group A placebo-controlled, double-blind study of the efficacy and safety of aripirazole in patients with acute bipolar mania American Journal of Psychiatry 160 2003 1651 1658
19. L.V. Kessing, L. Sondergard, K. Kvist, and P.K. Andersen Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study Bipolar Disorders 9 2007 730 736
20. D.J. Kupfer The increasing medical burden in bipolar disorder JAMA 293 2005 2528 2530
21. J. Levine, K.N. Chengappa, J.S. Brar, S. Gershon, E. Yablonsky, D. Stapf, and D.J. Kupfer Psychotropic drug prescription patterns among patients with bipolar I disorder Bipolar Disorders 2 2000 120 130
22. K.R. Merikangas, H.S. Akiskal, J. Angst, P.E. Greenberg, R.M.A. Hirschfeld, M. Petukhova, and R.C.M. Kessler Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication Archives of General Psychiatry 64 2007 543 552
23. A.A. Nierenberg, L.G. Sylvia, A.C. Leon, N.A. Reilly-Harrington, T.A. Ketter, J.R. Calabrese, M.E. Thase, C.L. Bowden, E.S. Friedman, M.J. Ostacher, L. Novak, and D.V. Iosifescu Lithium treatment - moderate dose use study (LiTMUS) for bipolar disorder: rationale and design Clinical Trials 6 2009 637 648
24. R.H. Perlis, G.S. Sachs, B. Lafer, M.W. Otto, S.V. Faraone, J.M. Kane, and J.F. Rosenbaum Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data American Journal of Psychiatry 159 2002 1155 1159
25. G. Sachs, F. Grossman, S.N. Gheami, A. Okamoto, and C. Bowden Combination of a Mood Stabilizer with Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety American Journal of Psychiatry 159 2002 1146 1154
26. G. Sachs, R. Sanchez, R. Marcus, E. Stock, R. McQuade, W. Carson, N. Abou-Gharbia, C. Impellizzeri, S. Kaplita, L. Rollin, and T. Iwamoto Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study Journal of Psychopharmacology 20 2006 536 546
27. W.E. Severus, N. Kleindienst, F. Seemuller, W. Frangou, H.J. Moller, and W. Greil What is the optimal serum level in the long-term treatment of bipolar disorder - a review Bipolar Disorders 10 2008 231 237
28. G.E. Simon Social and economic burden of mood disorders Biological Psychiatry 54 2003 208 215
29. T. Suppes, E.B. Dennehy, R.M.A. Hirschfeld, L.L. Altshuler, C.L. Bowden, J.R. Calabrese, M.L. Crismon, T.A. Ketter, G.S. Sachs, and A.C. Swann The texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder Journal of Clinical Psychiatry 66 2005 870 886
30. T. Suppes, E. Vieta, S. Liu, M. Brecher, B. Paulsson Trial 127 Investigators Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (Trial 127). American Journal of Psychiatry 166 2009 476 488
31. M.E. Thase, W. MacFadden, R.H. Weisler, W. Chang, B. Paulsson, A. Khan, and J.R. Calabrese Efficacy of quetiapine monotherapy in bipolar I and II depression - a double-blind, placebo-controlled study (the BOLDER II study) Journal of Clinical Psychopharmacology 26 2006 600 609
32. M. Tohen, T.A. Ketter, C.A. Zarate, T. Suppes, M. Frye, L. Altshuler, J. Zajecka, L.M. Schuh, R.C. Risser, E. Brown, and R.W. Baker Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study American Journal of Psychiatry 160 2003 1263 1271
33. M. Tohen, E. Vieta, J. Calabrese, T.A. Ketter, G. Sachs, C. Bowden, P.B. Mitchell, F. Centorrino, R. Risser, R.W. Baker, A.R. Evans, K. Beymer, S. Dubé, G.D. Tollefson, and A. Breier Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Archives of General Psychiatry 60 2003 1079 1088
34. M. Tohen, E. Vieta, J. Calabrese, T.A. Ketter, G. Sachs, C. Bowdon, P.B. Mitchell, F. Centorrino, R. Rissa, R.W. Baker, A.R. Evans, K. Beymer, S. Dube, G.D. Tollefson, and A. Breier Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar disorder Archives of General Psychiatry 60 2003 1079 1088
35. S.S. Tse, and A.E. Walsh How does work work for people with bipolar affective disorder? Occupational Therapy International 8 2001 210 225
36. E. Vieta, T. Suppes, I. Eggens, I. Persson, B. Paulsson, M. Brecher Trial 126 Study Investigators Efficacy and safety of quetiapine in combination with lithium for maintenance of patients with bipolar I disorder (International Trial 126) Journal of Affective Disorders 109 2008 251 263
37. C. Vojta, B. Kinosian, H. Glick, L. Altshuler, and M.S. Bauer Self-reported quality of life across mood states in bipolar disorder Comprehensive Psychiatry 42 2001 190 195